Method for providing combined radionuclide therapy for differentiated thyroid cancer with metastatic lesions of lungs and skeleton, involves carrying out course of combined therapy, and administering solution of radiopharmaceutical drug
	SHURINOV A I; KRYLOV V V; KOCHETOVA T D; BORODAVINA E V; IVANOV S A
	2023-12-12
专利权人	FEDERAL STATE BUDGETARY INST (FSBI-C)
申请日期	2023-12-12
专利号	RU2023132882-A; RU2824276-C2
成果简介	NOVELTY - The method involves carrying out course of combined radionuclide therapy, and administering solution of an osteotropic radiopharmaceutical drug intravenously after 24 hours. Distribution of RFLP in metastatic foci is assessed. Oral administration of an aqueous solution of sodium with radiotargeted RFLP after 72 hours. Subsequent courses of combined radionuclide therapy are carried out for every 4 months until onset of clinical effect. USE - Method for providing combined radionuclide therapy for differentiated thyroid cancer with metastatic lesions of lungs and skeleton.
IPC 分类号	A61M-036/00 ; A61K-051/02 ; A61P-035/04
国家	俄罗斯
专业领域	医药卫生
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/18956
专题	中国科学院新疆生态与地理研究所
作者单位	FEDERAL STATE BUDGETARY INST (FSBI-C)
推荐引用方式 GB/T 7714	SHURINOV A I,KRYLOV V V,KOCHETOVA T D,et al. Method for providing combined radionuclide therapy for differentiated thyroid cancer with metastatic lesions of lungs and skeleton, involves carrying out course of combined therapy, and administering solution of radiopharmaceutical drug. RU2023132882-A; RU2824276-C2[P]. 2023.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。